Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

✍ Scribed by Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; Chris H Polman; Paul W O'Connor; Gavin Giovannoni; J Theodore Phillips; Fred D Lublin; Amy Pace; Richard Kim; Robert Hyde

• Book ID: 114409138
• Publisher: The Lancet
• Year: 2009
• Tongue: English
• Weight: 170 KB
• Volume: 8
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(09)70021-3